1 Study Coverage 1.1 Diagnostic Nuclear Medicines Product Introduction 1.2 Global Diagnostic Nuclear Medicines Outlook 2017 VS 2022 VS 2028 1.2.1 Global Diagnostic Nuclear Medicines Sales in US$ Million for the Year 2017-2028 1.2.2 Global Diagnostic Nuclear Medicines Sales in Volume for the Year 2017-2028 1.3 United States Diagnostic Nuclear Medicines Outlook 2017 VS 2022 VS 2028 1.3.1 United States Diagnostic Nuclear Medicines Sales in US$ Million for the Year 2017-2028 1.3.2 United States Diagnostic Nuclear Medicines Sales in Volume for the Year 2017-2028 1.4 Diagnostic Nuclear Medicines Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Diagnostic Nuclear Medicines in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Diagnostic Nuclear Medicines Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Diagnostic Nuclear Medicines Market Dynamics 1.5.1 Diagnostic Nuclear Medicines Industry Trends 1.5.2 Diagnostic Nuclear Medicines Market Drivers 1.5.3 Diagnostic Nuclear Medicines Market Challenges 1.5.4 Diagnostic Nuclear Medicines Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Diagnostic Nuclear Medicines Market Segment by Type 2.1.1 Tc-99m 2.1.2 F-18 2.1.3 Other 2.2 Global Diagnostic Nuclear Medicines Market Size by Type 2.2.1 Global Diagnostic Nuclear Medicines Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Diagnostic Nuclear Medicines Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Diagnostic Nuclear Medicines Market Size by Type 2.3.1 United States Diagnostic Nuclear Medicines Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Diagnostic Nuclear Medicines Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Diagnostic Nuclear Medicines Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Diagnostic Nuclear Medicines Market Segment by Application 3.1.1 Oncology 3.1.2 Cardiology 3.1.3 Other 3.2 Global Diagnostic Nuclear Medicines Market Size by Application 3.2.1 Global Diagnostic Nuclear Medicines Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Diagnostic Nuclear Medicines Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Diagnostic Nuclear Medicines Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Diagnostic Nuclear Medicines Market Size by Application 3.3.1 United States Diagnostic Nuclear Medicines Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Diagnostic Nuclear Medicines Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Diagnostic Nuclear Medicines Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Diagnostic Nuclear Medicines Competitor Landscape by Company 4.1 Global Diagnostic Nuclear Medicines Market Size by Company 4.1.1 Top Global Diagnostic Nuclear Medicines Manufacturers Ranked by Revenue (2021) 4.1.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2017-2022) 4.1.3 Global Diagnostic Nuclear Medicines Sales by Manufacturer (2017-2022) 4.1.4 Global Diagnostic Nuclear Medicines Price by Manufacturer (2017-2022) 4.2 Global Diagnostic Nuclear Medicines Concentration Ratio (CR) 4.2.1 Diagnostic Nuclear Medicines Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Diagnostic Nuclear Medicines in 2021 4.2.3 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution, Product Type 4.3.1 Global Diagnostic Nuclear Medicines Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Diagnostic Nuclear Medicines Product Type 4.3.3 Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Diagnostic Nuclear Medicines Market Size by Company 4.5.1 Top Diagnostic Nuclear Medicines Players in United States, Ranked by Revenue (2021) 4.5.2 United States Diagnostic Nuclear Medicines Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Diagnostic Nuclear Medicines Sales by Players (2020, 2021 & 2022) 5 Global Diagnostic Nuclear Medicines Market Size by Region 5.1 Global Diagnostic Nuclear Medicines Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Diagnostic Nuclear Medicines Market Size in Volume by Region (2017-2028) 5.2.1 Global Diagnostic Nuclear Medicines Sales in Volume by Region: 2017-2022 5.2.2 Global Diagnostic Nuclear Medicines Sales in Volume Forecast by Region (2023-2028) 5.3 Global Diagnostic Nuclear Medicines Market Size in Value by Region (2017-2028) 5.3.1 Global Diagnostic Nuclear Medicines Sales in Value by Region: 2017-2022 5.3.2 Global Diagnostic Nuclear Medicines Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Diagnostic Nuclear Medicines Market Size YoY Growth 2017-2028 6.1.2 North America Diagnostic Nuclear Medicines Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Diagnostic Nuclear Medicines Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Diagnostic Nuclear Medicines Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Diagnostic Nuclear Medicines Market Size YoY Growth 2017-2028 6.3.2 Europe Diagnostic Nuclear Medicines Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Diagnostic Nuclear Medicines Market Size YoY Growth 2017-2028 6.4.2 Latin America Diagnostic Nuclear Medicines Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Diagnostic Nuclear Medicines Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Diagnostic Nuclear Medicines Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Bracco Imaging 7.1.1 Bracco Imaging Corporation Information 7.1.2 Bracco Imaging Description and Business Overview 7.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Bracco Imaging Diagnostic Nuclear Medicines Products Offered 7.1.5 Bracco Imaging Recent Development 7.2 Bayer 7.2.1 Bayer Corporation Information 7.2.2 Bayer Description and Business Overview 7.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Bayer Diagnostic Nuclear Medicines Products Offered 7.2.5 Bayer Recent Development 7.3 Curium Pharmaceuticals 7.3.1 Curium Pharmaceuticals Corporation Information 7.3.2 Curium Pharmaceuticals Description and Business Overview 7.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Products Offered 7.3.5 Curium Pharmaceuticals Recent Development 7.4 Nordion 7.4.1 Nordion Corporation Information 7.4.2 Nordion Description and Business Overview 7.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Nordion Diagnostic Nuclear Medicines Products Offered 7.4.5 Nordion Recent Development 7.5 Triad Isotopes 7.5.1 Triad Isotopes Corporation Information 7.5.2 Triad Isotopes Description and Business Overview 7.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Triad Isotopes Diagnostic Nuclear Medicines Products Offered 7.5.5 Triad Isotopes Recent Development 7.6 Lantheus 7.6.1 Lantheus Corporation Information 7.6.2 Lantheus Description and Business Overview 7.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Lantheus Diagnostic Nuclear Medicines Products Offered 7.6.5 Lantheus Recent Development 7.7 GE Healthcare 7.7.1 GE Healthcare Corporation Information 7.7.2 GE Healthcare Description and Business Overview 7.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.7.4 GE Healthcare Diagnostic Nuclear Medicines Products Offered 7.7.5 GE Healthcare Recent Development 7.8 China Isotope & Radiation 7.8.1 China Isotope & Radiation Corporation Information 7.8.2 China Isotope & Radiation Description and Business Overview 7.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Products Offered 7.8.5 China Isotope & Radiation Recent Development 7.9 Jubilant Pharma 7.9.1 Jubilant Pharma Corporation Information 7.9.2 Jubilant Pharma Description and Business Overview 7.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Products Offered 7.9.5 Jubilant Pharma Recent Development 7.10 Eli Lilly 7.10.1 Eli Lilly Corporation Information 7.10.2 Eli Lilly Description and Business Overview 7.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Eli Lilly Diagnostic Nuclear Medicines Products Offered 7.10.5 Eli Lilly Recent Development 7.11 Novartis 7.11.1 Novartis Corporation Information 7.11.2 Novartis Description and Business Overview 7.11.3 Novartis Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Novartis Diagnostic Nuclear Medicines Products Offered 7.11.5 Novartis Recent Development 7.12 SIEMENS 7.12.1 SIEMENS Corporation Information 7.12.2 SIEMENS Description and Business Overview 7.12.3 SIEMENS Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.12.4 SIEMENS Products Offered 7.12.5 SIEMENS Recent Development 7.13 Dongcheng 7.13.1 Dongcheng Corporation Information 7.13.2 Dongcheng Description and Business Overview 7.13.3 Dongcheng Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Dongcheng Products Offered 7.13.5 Dongcheng Recent Development 7.14 Navidea 7.14.1 Navidea Corporation Information 7.14.2 Navidea Description and Business Overview 7.14.3 Navidea Diagnostic Nuclear Medicines Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Navidea Products Offered 7.14.5 Navidea Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Diagnostic Nuclear Medicines Industry Chain Analysis 8.2 Diagnostic Nuclear Medicines Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Diagnostic Nuclear Medicines Distributors 8.3 Diagnostic Nuclear Medicines Production Mode & Process 8.4 Diagnostic Nuclear Medicines Sales and Marketing 8.4.1 Diagnostic Nuclear Medicines Sales Channels 8.4.2 Diagnostic Nuclear Medicines Distributors 8.5 Diagnostic Nuclear Medicines Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Diagnostic Nuclear Medicines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Diagnostic Nuclear Medicines Market Trends Table 3. Diagnostic Nuclear Medicines Market Drivers Table 4. Diagnostic Nuclear Medicines Market Challenges Table 5. Diagnostic Nuclear Medicines Market Restraints Table 6. Global Diagnostic Nuclear Medicines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Diagnostic Nuclear Medicines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Diagnostic Nuclear Medicines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Diagnostic Nuclear Medicines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Diagnostic Nuclear Medicines Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Diagnostic Nuclear Medicines Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturer, 2017-2022 Table 13. Global Diagnostic Nuclear Medicines Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Diagnostic Nuclear Medicines Sales Share by Manufacturer, 2017-2022 Table 15. Global Diagnostic Nuclear Medicines Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2021) Table 18. Top Players of Diagnostic Nuclear Medicines in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Diagnostic Nuclear Medicines Product Type Table 20. Date of International Manufacturers Enter into Diagnostic Nuclear Medicines Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Diagnostic Nuclear Medicines Players in United States Market, Ranking by Revenue (2021) Table 23. United States Diagnostic Nuclear Medicines Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Diagnostic Nuclear Medicines Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Diagnostic Nuclear Medicines Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Diagnostic Nuclear Medicines Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Diagnostic Nuclear Medicines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Diagnostic Nuclear Medicines Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Diagnostic Nuclear Medicines Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Diagnostic Nuclear Medicines Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Diagnostic Nuclear Medicines Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Diagnostic Nuclear Medicines Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Diagnostic Nuclear Medicines Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Diagnostic Nuclear Medicines Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Diagnostic Nuclear Medicines Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Diagnostic Nuclear Medicines Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Diagnostic Nuclear Medicines Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Diagnostic Nuclear Medicines Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Bracco Imaging Corporation Information Table 43. Bracco Imaging Description and Business Overview Table 44. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Bracco Imaging Diagnostic Nuclear Medicines Product Table 46. Bracco Imaging Recent Development Table 47. Bayer Corporation Information Table 48. Bayer Description and Business Overview Table 49. Bayer Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Bayer Product Table 51. Bayer Recent Development Table 52. Curium Pharmaceuticals Corporation Information Table 53. Curium Pharmaceuticals Description and Business Overview Table 54. Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Curium Pharmaceuticals Product Table 56. Curium Pharmaceuticals Recent Development Table 57. Nordion Corporation Information Table 58. Nordion Description and Business Overview Table 59. Nordion Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Nordion Product Table 61. Nordion Recent Development Table 62. Triad Isotopes Corporation Information Table 63. Triad Isotopes Description and Business Overview Table 64. Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Triad Isotopes Product Table 66. Triad Isotopes Recent Development Table 67. Lantheus Corporation Information Table 68. Lantheus Description and Business Overview Table 69. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Lantheus Product Table 71. Lantheus Recent Development Table 72. GE Healthcare Corporation Information Table 73. GE Healthcare Description and Business Overview Table 74. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. GE Healthcare Product Table 76. GE Healthcare Recent Development Table 77. China Isotope & Radiation Corporation Information Table 78. China Isotope & Radiation Description and Business Overview Table 79. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. China Isotope & Radiation Product Table 81. China Isotope & Radiation Recent Development Table 82. Jubilant Pharma Corporation Information Table 83. Jubilant Pharma Description and Business Overview Table 84. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Jubilant Pharma Product Table 86. Jubilant Pharma Recent Development Table 87. Eli Lilly Corporation Information Table 88. Eli Lilly Description and Business Overview Table 89. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Eli Lilly Product Table 91. Eli Lilly Recent Development Table 92. Novartis Corporation Information Table 93. Novartis Description and Business Overview Table 94. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Novartis Product Table 96. Novartis Recent Development Table 97. SIEMENS Corporation Information Table 98. SIEMENS Description and Business Overview Table 99. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. SIEMENS Product Table 101. SIEMENS Recent Development Table 102. Dongcheng Corporation Information Table 103. Dongcheng Description and Business Overview Table 104. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 105. Dongcheng Product Table 106. Dongcheng Recent Development Table 107. Navidea Corporation Information Table 108. Navidea Description and Business Overview Table 109. Navidea Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 110. Navidea Product Table 111. Navidea Recent Development Table 112. Key Raw Materials Lists Table 113. Raw Materials Key Suppliers Lists Table 114. Diagnostic Nuclear Medicines Customers List Table 115. Diagnostic Nuclear Medicines Distributors List Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Diagnostic Nuclear Medicines Product Picture Figure 2. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Diagnostic Nuclear Medicines Market Size 2017-2028 (US$ Million) Figure 4. Global Diagnostic Nuclear Medicines Sales 2017-2028 (K Units) Figure 5. United States Diagnostic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Diagnostic Nuclear Medicines Market Size 2017-2028 (US$ Million) Figure 7. United States Diagnostic Nuclear Medicines Sales 2017-2028 (K Units) Figure 8. United States Diagnostic Nuclear Medicines Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Diagnostic Nuclear Medicines Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Diagnostic Nuclear Medicines Report Years Considered Figure 11. Product Picture of Tc-99m Figure 12. Product Picture of F-18 Figure 13. Product Picture of Other Figure 14. Global Diagnostic Nuclear Medicines Market Share by Type in 2022 & 2028 Figure 15. Global Diagnostic Nuclear Medicines Sales in Value by Type (2017-2028) & (US$ Million) Figure 16. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Type (2017-2028) Figure 17. Global Diagnostic Nuclear Medicines Sales by Type (2017-2028) & (K Units) Figure 18. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Type (2017-2028) Figure 19. Global Diagnostic Nuclear Medicines Price by Type (2017-2028) & (USD/Unit) Figure 20. United States Diagnostic Nuclear Medicines Market Share by Type in 2022 & 2028 Figure 21. United States Diagnostic Nuclear Medicines Sales in Value by Type (2017-2028) & (US$ Million) Figure 22. United States Diagnostic Nuclear Medicines Sales Market Share in Value by Type (2017-2028) Figure 23. United States Diagnostic Nuclear Medicines Sales by Type (2017-2028) & (K Units) Figure 24. United States Diagnostic Nuclear Medicines Sales Market Share in Volume by Type (2017-2028) Figure 25. United States Diagnostic Nuclear Medicines Price by Type (2017-2028) & (USD/Unit) Figure 26. Product Picture of Oncology Figure 27. Product Picture of Cardiology Figure 28. Product Picture of Other Figure 29. Global Diagnostic Nuclear Medicines Market Share by Application in 2022 & 2028 Figure 30. Global Diagnostic Nuclear Medicines Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Diagnostic Nuclear Medicines Sales Market Share in Value by Application (2017-2028) Figure 32. Global Diagnostic Nuclear Medicines Sales by Application (2017-2028) & (K Units) Figure 33. Global Diagnostic Nuclear Medicines Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Diagnostic Nuclear Medicines Price by Application (2017-2028) & (USD/Unit) Figure 35. United States Diagnostic Nuclear Medicines Market Share by Application in 2022 & 2028 Figure 36. United States Diagnostic Nuclear Medicines Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Diagnostic Nuclear Medicines Sales Market Share in Value by Application (2017-2028) Figure 38. United States Diagnostic Nuclear Medicines Sales by Application (2017-2028) & (K Units) Figure 39. United States Diagnostic Nuclear Medicines Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Diagnostic Nuclear Medicines Price by Application (2017-2028) & (USD/Unit) Figure 41. North America Diagnostic Nuclear Medicines Sales in Volume Growth Rate 2017-2028 (K Units) Figure 42. North America Diagnostic Nuclear Medicines Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Diagnostic Nuclear Medicines Sales in Volume Growth Rate 2017-2028 (K Units) Figure 46. Europe Diagnostic Nuclear Medicines Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Diagnostic Nuclear Medicines Sales in Volume Growth Rate 2017-2028 (K Units) Figure 53. Asia-Pacific Diagnostic Nuclear Medicines Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Diagnostic Nuclear Medicines Sales in Volume Growth Rate 2017-2028 (K Units) Figure 65. Latin America Diagnostic Nuclear Medicines Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Diagnostic Nuclear Medicines Sales in Volume Growth Rate 2017-2028 (K Units) Figure 70. Middle East & Africa Diagnostic Nuclear Medicines Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Diagnostic Nuclear Medicines Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Diagnostic Nuclear Medicines Value Chain Figure 75. Diagnostic Nuclear Medicines Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Bracco Imaging Bayer Curium Pharmaceuticals Nordion Triad Isotopes Lantheus GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Novartis SIEMENS Dongcheng Navidea